Importance To our knowledge, a set of well-defined diagnostic criteria is not yet developed
for the diagnosis of Vogt-Koyanagi-Harada (VKH) disease. Objective To develop and …

… They found that most patients with the Harada’s form of VKH disease (exudative retinal
detachment and mild anterior uveitis) required less than 100 mg of prednisone daily for adequate …

… Biologics are increasingly used to treat Vogt-Koyanagi-Harada disease, but head-to-head …
11.2 letters (95% CI, 7.5 to 14.9) in the cyclosporine group and 6.3 letters (95% CI, 3.1 to 9.6…

Objective: The aim of this study was to evaluate the association of human leukocyte antigen
(HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt–Koyanagi–Harada (VKH), providing …

… Sex-specific rates are presented in Figure 3; prevalence was higher in men at 1.62 (95%
CI, 0.93-2.31) per 1000 persons and lower in women at 0.87 (95% CI, 0.37-1.37) per 1000 …

… Citation15 Use of the terms “Harada’s disease” to describe inflammation limited to the eye
– a misnomer since Dr. Einosuke Harada himself described uveitis in association with both …

… The 95% CI of the hazard ratio was less than 1, indicating an antagonistic interaction, ie
immediate IMT decreased the relapse hazard in the context of the high-risk group. …

In order to determine the ultimate molecular resolution attainable with a conventional electron
microscope, the direct observation of hexadecachloro‐Cu‐phthalocyanine molecules was …

… CI, 4.3 to 9.5 cancers per 1000 screenings] in the intervention group vs 14 cancers [3.6 cancers
per 1000 screenings; 95% CI, … per 1000 screenings; 95% CI, 0.1 to 1.0 cancers per 1000 …

… On multivariate analysis, HBV infection (OR=13.9; 95% CI=5.78–33.6) and history of
intravenous injection (OR=2.72; 95% CI=1.24–6.00) were still associated with significantly …